Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers

Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis

ClinicalTrials.gov ID: NCT00230867

Public ClinicalTrials.gov record NCT00230867. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Placebo Controlled, Randomized, Double Blind, Subject Initiated Study of the Safety and Efficacy of a Single Topical Iontophoretic Application of Acyclovir 5% Cream With an Open Label Conventional Therapy Treatment Arm, and a Blinded Evaluator, for the Treatment of Recurrent Herpes Labialis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Currently approved drugs for the treatment of herpes labialis (cold sores) exhibit low levels of efficacy due to the limited ability of the drugs to penetrate the skin to the site where the herpes virus is replicating. Iontophoresis uses electric current to enhance the delivery of drugs through the skin. This trial is testing a new iontophoretic device for the delivery of acyclovir cream to treat cold sores.

Study identification

NCT ID
NCT00230867
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Transport Pharmaceuticals
Industry
Enrollment
1,800 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2005 (Type not available)
Primary completion
Not listed
Completion
Dec 2005 (Type not available)
Last update posted
Jul 4, 2006

2005

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Radiant Research Birmingham Birmingham Alabama 35209 —
Radiant Research Phoenix Southeast Chandler Arizona 85225 —
Radiant Research Phoenix Phoenix Arizona 85013 —
Radiant Research Scottsdale Scottsdale Arizona 85251 —
Radiant Research San Diego San Diego California 92123 —
Radiant Research Santa Rosa Santa Rosa California 95405 —
Radiant Research St. Petersburg Pinellas Park Florida 33781 —
Radiant Research Stuart Stuart Florida 34996 —
Radiant Research West Palm West Palm Beach Florida 33407 —
Radiant Research Atlanta West Atlanta Georgia 30308 —
Radiant Research Atlanta Atlanta Georgia 30342 —
Radiant Research Boise Boise Idaho 83704 —
Radiant Research Chicago Chicago Illinois 60610 —
Radiant Research Minneapolis Edina Minnesota 55435 —
Radiant Research St. Louis St Louis Missouri 63141 —
Rochester Clinical Research, Inc. Rochester New York 14609 —
Radiant Research Cincinnati Cincinnati Ohio 45236 —
Pediatric Clinical Trials International Columbus Ohio 43205 —
Radiant Research Philadelphia Philadelphia Pennsylvania 19115 —
Radiant Research Greer Greer South Carolina 29651 —
J & S Studies, Inc. Bryan Texas 77802 —
Radiant Research Dallas North Dallas Texas 75231 —
Radiant Research San Antonio San Antonio Texas 78229 —
Univeristy of Utah Health Sciences Salt Lake City Utah 84132 —
Dermatology & Laser Center NW Bellingham Washington 98225 —
Radiant Research Tacoma Lakewood Washington 98499 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00230867, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 4, 2006 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00230867 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →